We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Sensor Detects Lactate Levels in Individual Cancer Cells

By LabMedica International staff writers
Posted on 25 Mar 2013
A team of scientists devised a molecular sensor that detects levels of lactate in individual cells. More...
A high rate of lactate production indicates that cancer is present, via diagnostics such as positron emission tomography (PET) scans, and may offer an opportunity for novel cancer therapies.

The scientists used a bacterial transcription factor—a protein that binds to specific DNA sequences to control the flow of genetic information from DNA to mRNA—as a means to produce and insert the lactate sensor. They turned on the sensor in three cell types: normal brain cells, tumor brain cells, and human embryonic cells. The sensor was able to quantify very low concentrations of lactate, providing good sensitivity and range of detection. Sugars are broken up by cancer cells and produce the metabolic acid lactate at a much greater rate than normal cells. The tumor cells produced lactate three to five times faster than the nontumor cells.

“The high rate of lactate production in the cancer cell is the hallmark of cancer metabolism,” remarked Prof. Frommer. “This result paves the way for understanding the nuances of cancer metabolism in different types of cancer and for developing new techniques for combating this scourge.”

Chilean researchers from the Centro de Estudios Científicos (CECs; Valdivia, Chile) with the collaboration of Carnegie’s Institute of Washington (Washington DC, USA) Prof. Wolf Frommer devised the molecular sensor that detects levels of lactate in individual cells. Prior to this advance, no other measurement method could noninvasively detect lactate in real time at the single-cell level. The work, published in the February 26, 2013, edition of the open access journal PLOS ONE, is a boon to understanding how different types of cells go awry when cancer hits.

The biosensors also might be able to solve an old controversy. While some studies have suggested the glucose provides fuel for the brain, recent research has provided evidence that lactate feeds energy metabolism in neurons. Oxidation of lactate can be used to produce large amounts of adenosine tri-phosphate (ATP), the coenzyme that carries energy in cells. The Barros and Frommer teams are excited about the possibility of solving this enigma with the use of their new sensors, together with previously developed glucose sensors.

“Over the last decade, the [Wolf] Frommer lab at Carnegie’s Institution of has pioneered the use of Förster resonance energy transfer, or FRET, sensors to measure the concentration and flow of sugars in individual cells with a simple fluorescent color change. This has started to revolutionize the field of cell metabolism,” explained CECs researcher Alejandro San Martin, lead author of the article. “Using the same underlying physical principle and inspired by the sugar sensors, we have now invented a new type of sensor based on a transcriptional factor. A molecule that normally helps bacteria to adapt to its environment has now been tricked into measuring lactate for us.”

Related Links:
Centro de Estudios Científicos
Carnegie’s Institute of Washington


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.